Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Conditions

• Nonalcoholic Steatohepatitis (NASH)
• Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
• Non-alcoholic Fatty Liver Disease (NAFLD)

Interventions

• DRUG: Miricorilant

Sponsor

Corcept Therapeutics

Collaborators

• [object Object]